Clinuvl Phrmaceu (CUVL) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 6 32 sessions, July 20, 2026 to September 4, 2026
- Largest daily move
- -11.4% close of August 27, 2026
Company Description
Clinuvl Phrmaceu (NASDAQ: CUVL) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $328.8M, ranking #4,134 among all listed U.S. companies by market cap.
CUVL has declined 4.7% over the past month. Shares last traded at $6.52.
This page collects what Stock Titan holds for CUVL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clinuvl Phrmaceu (CUVL) stock last closed at $6.52. Over the past month, the stock has lost 4.7%. At a market capitalization of $328.8M, CUVL is classified as a small-cap stock with approximately 50.4M shares outstanding.
Latest News
Clinuvl Phrmaceu has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. View all CUVL news →
SEC Filings
Clinuvl Phrmaceu has filed 3 recent SEC filings, including 3 Form 6-K. The most recent filing was submitted on August 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CUVL SEC filings →
Financial Highlights
Upcoming Events
Headquarters relocation
Workforce reduction
Clinuvl Phrmaceu has 2 upcoming scheduled events. The next event, "Headquarters relocation", is scheduled for January 1, 2027 (in 114 days). Investors can track these dates to stay informed about potential catalysts that may affect the CUVL stock price.
Short Interest History
Short interest in Clinuvl Phrmaceu (CUVL) currently stands at 1.2 thousand shares, up 811.8% from the previous reporting period, representing 0.0% of the float. Since July 2026, short interest has increased by 811.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Clinuvl Phrmaceu (CUVL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CUVL Company Profile & Sector Positioning
Clinuvl Phrmaceu (CUVL) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. Among dividend-paying stocks, CUVL ranks #2,062 by dividend yield. In monthly performance, the stock ranks #809 among all tracked companies.